Rose Capital is a leading investment firm within the global legal cannabis sector that is focused on providing strategic capital and fostering growth-oriented operating partnerships.

About Us

Our team brings brand name, blue-chip financial and management pedigree to the nascent cannabis market, lending our expertise across all partnerships. With investments in several of the largest and most strategic assets in their respective verticals, Rose Capital has established itself as a preeminent cannabis-driven investment house.

Our origins in cannabis date back to 2009, when our founders initiated diligence on the industry and early investment opportunities. In 2014, after analyzing dozens of assets, Rose made its inaugural investment in Eaze, an on-demand delivery service for cannabis products. Over the last five years, our portfolio has grown to encompass some of the cannabis industry’s most prominent and powerful names, including Mary’s Brands, Helix TCS / BioTrackTHC, and Eaze. To date, the Rose ecosystem spans 11 states.

We are a diverse team of professionals that leverages our experience in the cannabis markets, financial acumen, expertise of capital markets and strategic advisory abilities to unlock opportunities for operating teams, employees, and investors. With aims of maximizing upside yield while mitigating downside risk, our assets work synergistically to deliver outsized returns.

Rose Capital is the founder and exclusive financial partner of BR Brands, a CPG platform within the global legal cannabis sector that amalgamates best-in-class brands under its common umbrella. Through a buy and build strategy, BR Brands expands its portfolio with brands that share the same vision of integrity, commitment to consistent dosing, and product efficacy. BR Brands markets and sells products across a large geographic footprint that is currently unparalleled by any other cannabis brand. These products range in offerings from adult-use concentrates, confections, and beverages to full-spectrum tinctures, serums and other skincare products.

Portfolio

Investment Strategy

Rose Capital is a long-term value-oriented investment platform, rooted in partnership with talented operating teams. In partnership with management, we create bespoke investment structures that service cannabis operators’ goals with a focus on the verticals of data & analytics, distribution & logistics, consumer packaged goods and ancillary products.

With a team that possesses exceptional financial service pedigrees, ranging from distressed credit to both private and public equity expertise, we are opportunistic in designing tailored investment structures to meet the individual needs of our operators and assets.

Our background in executing complicated transactions provides a competitive advantage in addressing the unique needs of each operating partner. These needs, coupled with macroeconomic considerations, inform Rose’s investment structures, which span across the spectrum of traditional lending, growth equity, control buyouts, distressed lending / restructurings, as well as public investing.

Team

linked-in

Andrew Schweibold

Co-Founder & Chief Executive Officer

linked-in

Sat Joshi

Chief Investment Officer

linked-in

Arin Aragona

Chief Operating Officer & General Counsel

linked-in

Sarah Rigden

Chief People Officer & Head of Portfolio Talent

linked-in

John Forté

Head of Strategic Partnerships

linked-in

Eileen Kavanagh

Financial Controller

linked-in

Roger Klauer

Head of Business Development

linked-in

Joseph Perez

Principal

linked-in

Jillian Scheidler

Chief of Staff

linked-in

David Shi

Principal

linked-in

Tim Simon

Head of Capital Markets

linked-in

Ben Slome

Director of Operations

linked-in

Kenny Turano

Principal

linked-in

Dustin Byrne

Chief Technology Officer

linked-in

Marc Esquenazi

Chief Financial Officer

linked-in

Jacques Panis

VP of Brand Incubation

linked-in

Robert Profusek

GM & Head of Creative

linked-in

Dr. Mark Scialdone

Chief Science Officer

linked-in

Jen Turano

Head of Integrated Marketing

News & Press

News

Contact

+1 203-904-2202

Rose Capital
41 West Putnam Avenue
Greenwich CT 06830
United States

Newsletter sign-up